Connect Biopharma is trading 5.7% up at $2.21 in pre-market, building on yesterday's modest gains and a stronger move in after-hours trading.
- The stock's advance comes despite a lack of new company-specific news or earnings reports.
- The price action is broadly aligned with a risk-on market sentiment and strength in major U.S. indices, which are also trading higher.